<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "https://foliamedica.bg/nlm/tax-treatment-NS0.dtd">
<article xmlns:tp="http://www.plazi.org/taxpub" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">87</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:A116C711-4C18-5A38-8F1E-5E97753A8A64</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Folia Medica</journal-title>
        <abbrev-journal-title xml:lang="en">FM</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0204-8043</issn>
      <issn pub-type="epub">1314-2143</issn>
      <publisher>
        <publisher-name>Plovdiv Medical University</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/folmed.68.e192711</article-id>
      <article-id pub-id-type="publisher-id">192711</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Invited Review</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Pathophysiology</subject>
          <subject>Sport medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cardiopulmonary exercise testing in children: application and interpretation challenges</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Byandova</surname>
            <given-names>Aglika</given-names>
          </name>
          <email xlink:type="simple">abyandova@pathophysiology.info</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Marinov</surname>
            <given-names>Blagoy</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0001-9640-1906</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Department of Pathophysiology, Medical University of Plovdiv, Plovdiv, Bulgaria</addr-line>
        <institution>Department of Pathophysiology, Medical University of Plovdiv</institution>
        <addr-line content-type="city">Plovdiv</addr-line>
        <country>Bulgaria</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p><bold>Corresponding author</bold>: Aglika Byandova, Department of Pathophysiology, Medical University of Plovdiv, 15A Vassil Aprilov Blvd., 4002 Plovdiv, Bulgaria; Email: <email xlink:type="simple">abyandova@pathophysiology.info</email></p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2026</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>08</month>
        <year>2026</year>
      </pub-date>
      <volume>68</volume>
      <issue>4</issue>
      <elocation-id>e192711</elocation-id>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/9040BD6C-AB2B-5ECC-B143-D0CD96950567">9040BD6C-AB2B-5ECC-B143-D0CD96950567</uri>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>03</month>
          <year>2026</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>03</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Aglika Byandova, Blagoy Marinov</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>
          <bold>Abstract</bold>
        </p>
        <p>Cardiopulmonary exercise testing (<abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev>) is a complex functional test that allows for dynamic monitoring of the cardiovascular and respiratory systems during progressive incremental physical activity. <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> is well-established in adult patients, as it provides diagnostic and prognostic value. Pediatric <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> proves informative, although it entails numerous challenges, stemming from the developmental characteristics of children, as well as factors regarding test conduction and interpretation.</p>
        <p>Pediatric <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> applicability ranges from estimating exercise capacity in healthy and athletic children to diagnosis and prognosis in cases of chronic disease, such as respiratory or cardiovascular conditions. It can be used as a basis for the assessment of functional capacity in cases of asthma and cystic fibrosis, as well as quality of life scoring in kids with chronic heart failure. Furthermore, exercise testing is used as part of the indirect bronchoprovocation procedures for pulmonary function testing.</p>
        <p>Main challenges include the lack of standardized reference values, protocol selection, and the need for special pediatric equipment, as well as the high cost associated with the test.</p>
        <p><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> represents a valuable and increasingly utilized tool for assessment of the pediatric population. Future studies should focus on establishing normative datasets and improving methodological standardization.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>cardiopulmonary exercise testing</kwd>
        <kwd>children</kwd>
        <kwd>exercise</kwd>
        <kwd>pediatric</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="Citation" id="sec1">
        <title>Citation</title>
        <p>Byandova A, Marinov B. Cardiopulmonary exercise testing in children: application and interpretation challenges. Folia Med (Plovdiv) 2026;68(4):е192711. <ext-link ext-link-type="doi" xlink:href="10.3897/folmed.68.e192711">doi: 10.3897/folmed.68.e192711</ext-link>.</p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="Introduction" id="sec2">
      <title>Introduction</title>
      <p>Cardiopulmonary exercise testing (<abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev>) allows for the simultaneous evaluation of cardiovascular, respiratory, and metabolic responses during progressive incremental physical activity. <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> provides insight into the integrated physiological response to exercise and enables identification of the dominant mechanism of exercise limitation-cardiac, pulmonary, peripheral, or mixed. This places it at the center of modern functional diagnostics.</p>
      <p>Recently the <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> application has expanded to include more actively the pediatric population. Childhood is characterized by rapid growth and developmental changes that significantly affect cardiovascular, respiratory, and muscular function. In this context the assessment of functional capacity at rest is often insufficient and does not reflect the real capabilities of the body.</p>
      <p>Conducting and interpreting pediatric <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> presents specific challenges related to developmental physiology, protocol, and ergometer selection and safety considerations as well as motivational factors. This review summarizes the principles, clinical applications, and current challenges of <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> in the pediatric population.</p>
    </sec>
    <sec sec-type="Developmental differences in the physiological response to exercise" id="sec3">
      <title>Developmental differences in the physiological response to exercise</title>
      <p>Age-related differences in cardiorespiratory response and peripheral muscle utilization lead to specific patterns of adaptation in children during exercise. This requires a careful individual approach to analyzing and interpreting the results of <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> in children.</p>
      <p>Children have higher heart rate (<abbrev xlink:title="heart rate">HR</abbrev>), both at rest and during physical activity.<sup>[<xref ref-type="bibr" rid="B1">1</xref>]</sup> This is compensated for by a relatively lower stroke volume (<abbrev xlink:title="stroke volume">SV</abbrev>), so that cardiac output (Q) during exercise remains similar per unit of body mass.‌<sup>[<xref ref-type="bibr" rid="B2">2</xref>]</sup> Blood pressure (<abbrev xlink:title="Blood pressure">BP</abbrev>) rise is less prominent due to lower peripheral vascular resistance.<sup>[<xref ref-type="bibr" rid="B3">3</xref>]</sup> Children have a limited ability to increase the arteriovenous oxygen difference (a-vO<sub>2</sub> difference), probably as a reflection of the more limited compensatory abilities of the cardiovascular system.<sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup> Children demonstrate weaker baroreflex sensitivity and a limited catecholamine response to exercise, which affects their adaptive capacity.<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup></p>
      <p>Children and adolescents have lower tidal volume (<abbrev xlink:title="lower tidal volume">Vt</abbrev>), higher respiratory rate (<abbrev xlink:title="higher respiratory rate">RR</abbrev>), and relatively lower mechanical efficiency of breathing compared to adults.<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup> They respond to physical exertion with a sharp increase in minute ventilation (<abbrev xlink:title="ventilation">VE</abbrev>), but the <abbrev xlink:title="ventilation">VE</abbrev>/VCO<sub>2</sub> ratio remains higher, indicating lower ventilatory efficiency.<sup>[<xref ref-type="bibr" rid="B6">6</xref>]</sup> Children typically achieve lower peak oxygen consumption (VO<sub>2</sub>peak) and reach ventilatory thresholds earlier at lower <abbrev xlink:title="heart rate">HR</abbrev> and VO<sub>2</sub>.<sup>[<xref ref-type="bibr" rid="B7">7</xref>]</sup></p>
      <p>Young children have a predominance of type 1 “fast” oxidative muscle fibers, which is consistent with a predominantly aerobic physiology.<sup>[<xref ref-type="bibr" rid="B8">8</xref>]</sup> Their mechanical efficiency of movement is lower due to poor coordination and higher energy cost.<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup> Young children have a higher body surface area to volume ratio as well as insufficient thermoregulatory mechanisms - factors that hinder effective heat dissipation and predispose to overheating, especially in conditions of increased temperature and humidity.<sup>[<xref ref-type="bibr" rid="B9">9</xref>]</sup></p>
    </sec>
    <sec sec-type="Key parameters of interest in pediatric CPET" id="sec4">
      <title>Key parameters of interest in pediatric CPET</title>
      <sec sec-type="Oxygen consumption (VO2)" id="sec5">
        <title>Oxygen consumption (VO<sub>2</sub>)</title>
        <p>VO<sub>2</sub> is the primary indicator of aerobic metabolic capacity. It reflects the interaction between pulmonary ventilation, cardiovascular transport, and peripheral utilization of oxygen in the working muscles and is considered the “gold standard” for assessing the aerobic capacity of the individual. VO<sub>2</sub> increases linearly with workload increase until the maximal value (VO<sub>2</sub>max) is reached.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup> In children, reaching a clearly defined VO<sub>2</sub> plateau is not always possible. Therefore, the term “peak oxygen consumption” (VO<sub>2</sub>peak) is used, which denotes the highest value of VO<sub>2</sub> reached during the test.<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup> VO<sub>2</sub>peak is an acceptable and clinically applicable indicator in the pediatric population, provided that the test is performed with a sufficiently high intensity.<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup> The difficulties in reaching true maximal exercise in children also necessitate the introduction of submaximal assessment parameters that are valid even in the absence of maximal effort.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup></p>
      </sec>
      <sec sec-type="Ventilatory thresholds" id="sec6">
        <title>Ventilatory thresholds</title>
        <p>Ventilatory thresholds are key metabolic points during exercise that mark the characteristic changes in the metabolic processes for energy production required for muscle contraction. The first ventilatory threshold (<abbrev xlink:title="first ventilatory threshold">VT1</abbrev>), also called the anaerobic threshold (<abbrev xlink:title="anaerobic threshold">AT</abbrev>), reflects the beginning of additional CO<sub>2</sub> production, which is an expression of the increasing reliance on anaerobic metabolic pathways. This is accompanied by the incipient development of metabolic acidosis. The second ventilatory threshold (<abbrev xlink:title="second ventilatory threshold">VT2</abbrev>), called by Wasserman the respiratory compensation point (<abbrev xlink:title="respiratory compensation point">RCP</abbrev>), marks the moment of a disproportionate increase in ventilation relative to CO<sub>2</sub> production and is associated with the exhaustion of the compensatory mechanisms for maintaining normal acid-base balance.<sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup></p>
        <p>In children, ventilatory thresholds often occur at a relatively higher percentage of VO<sub>2</sub>peak compared to adults. This is thought to be related to developmental differences in muscle metabolism, including low glycolytic enzyme activity, reduced lactate production, and a greater reliance on oxidative pathways during exercise.<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup> As a result, children often demonstrate a more gradual transition from purely aerobic to mixed (aerobic and anaerobic) energy production.</p>
      </sec>
      <sec sec-type="Respiratory exchange ratio (RER)" id="sec7">
        <title>Respiratory exchange ratio (RER)</title>
        <p>The respiratory exchange ratio (<abbrev xlink:title="respiratory exchange ratio">RER</abbrev>), defined as the ratio of carbon dioxide production to oxygen consumption (VCO<sub>2</sub>/VO<sub>2</sub>), reflects substrate utilization during exercise. At rest and during low-intensity exercise, <abbrev xlink:title="respiratory exchange ratio">RER</abbrev> values are typically below 1.0, indicating predominant fat oxidation. With increasing exercise intensity and greater reliance on carbohydrate metabolism, <abbrev xlink:title="respiratory exchange ratio">RER</abbrev> rises and may exceed 1.0 due to additional CO<sub>2</sub> production from buffering of exercise-induced metabolic acidosis.</p>
        <p>In pediatric populations, peak <abbrev xlink:title="respiratory exchange ratio">RER</abbrev> values during maximal exercise are often lower than those observed in adults.<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup> This might be related to differences in metabolic characteristics, including lower glycolytic capacity, earlier peripheral fatigue, or motivational factors. Consequently, the adult maximality criterion of <abbrev xlink:title="respiratory exchange ratio">RER</abbrev> &gt;1.10–1.11 may not always be appropriate in children. Some studies suggest that <abbrev xlink:title="respiratory exchange ratio">RER</abbrev> values around 1.00–1.05 may already indicate near-maximal effort when accompanied by other markers such as high <abbrev xlink:title="heart rate">HR</abbrev>, VO<sub>2</sub> plateau, or signs of fatigue.<sup>[<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B13">13</xref>]</sup> Therefore, <abbrev xlink:title="respiratory exchange ratio">RER</abbrev> in children should be interpreted in the context of other indicators assessing the overall exercise performance.</p>
      </sec>
      <sec sec-type="Ventilatory efficiency and its slope (VE/VCO2 slope)" id="sec8">
        <title>Ventilatory efficiency and its slope (VE/VCO<sub>2</sub> slope)</title>
        <p>The relationship between minute ventilation (<abbrev xlink:title="ventilation">VE</abbrev>) and carbon dioxide production (VCO<sub>2</sub>) is referred to as ventilatory efficiency (<abbrev xlink:title="ventilation">VE</abbrev>/VCO<sub>2</sub>). The ventilatory efficiency slope is typically calculated using linear regression of <abbrev xlink:title="ventilation">VE</abbrev> against VCO<sub>2</sub> from the onset of exercise until <abbrev xlink:title="second ventilatory threshold">VT2</abbrev>/<abbrev xlink:title="respiratory compensation point">RCP</abbrev><sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup><bold>(Fig. <xref ref-type="fig" rid="F1">1</xref>)</bold>. It is one of the most stable and clinically relevant indicators in <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev>, as it reflects the extent to which ventilation can ensure the elimination of CO<sub>2</sub> during increment exercise.<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup></p>
        <fig id="F1">
          <object-id content-type="arpha">04646B4D-8289-5C5C-A7A3-36340BF8B876</object-id>
          <label>Figure 1.</label>
          <caption>
            <p>Relationship between <abbrev xlink:title="ventilation">VE</abbrev> and VCO<sub>2</sub> during incremental exercise, illustrating the <abbrev xlink:title="ventilation">VE</abbrev>/VCO<sub>2</sub> slope. The solid line represents higher ventilatory efficiency, whereas the dotted line – lower ventilatory efficiency</p>
          </caption>
          <graphic xlink:href="foliamedica-68-4-e192711-g001.jpg" id="oo_1750208.jpg">
            <uri content-type="original_file">https://binary.pensoft.net/fig/1750208</uri>
          </graphic>
        </fig>
        <p>In children, developmental characteristics including higher <abbrev xlink:title="higher respiratory rate">RR</abbrev>, smaller <abbrev xlink:title="lower tidal volume">Vt</abbrev>, and different lung mechanics can affect the absolute values of the <abbrev xlink:title="ventilation">VE</abbrev>/VCO<sub>2</sub> slope. Therefore, the use of age-, sex- and height-specific reference values is essential. The ventilatory efficiency slope is informative even at submaximal effort, which makes it a suitable parameter for assessment in individuals who cannot achieve maximum exercise.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup></p>
      </sec>
      <sec sec-type="Oxygen uptake efficiency and oxygen uptake efficiency slope" id="sec9">
        <title>Oxygen uptake efficiency and oxygen uptake efficiency slope</title>
        <p>Oxygen uptake efficiency (<abbrev xlink:title="Oxygen uptake efficiency">OUE</abbrev>) reveals the relationship between VO<sub>2</sub> and <abbrev xlink:title="ventilation">VE</abbrev> during incremental physical activity. This metric is based on the logarithmic relationship between the two parameters, which is graphically expressed by a regression slope, known as the oxygen uptake efficiency slope (<abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev>).<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup> (<bold>Equation 1</bold>. Logarithmic relationship between ventilation and oxygen consumption during physical exertion; <bold>Fig. <xref ref-type="fig" rid="F2">2</xref></bold>) This metric reflects the ability of an individual to increase VO<sub>2</sub> by increasing ventilation and is considered an integral marker of cardiorespiratory efficiency.<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup></p>
        <fig id="F2">
          <object-id content-type="arpha">9CDA0A12-169A-501D-87C0-884777BCEE29</object-id>
          <label>Figure 2.</label>
          <caption>
            <p>Relationship between VO<sub>2</sub> and the logarithm of <abbrev xlink:title="ventilation">VE</abbrev> during progressive incremental exercise, known as the oxygen uptake efficiency slope (<abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev>). The solid line represents higher <abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev>, while the dotted line – lower <abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev>.</p>
          </caption>
          <graphic xlink:href="foliamedica-68-4-e192711-g002.jpg" id="oo_1750209.jpg">
            <uri content-type="original_file">https://binary.pensoft.net/fig/1750209</uri>
          </graphic>
        </fig>
        <p>VO<sub>2</sub> = a × log<sub>10</sub><abbrev xlink:title="ventilation">VE</abbrev> + b (Equ. 1)</p>
        <p>A significant advantage of oxygen uptake efficiency slope is its relative independence from the test duration and the achievement of maximum effort.<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup> As such, <abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev> can be reliably calculated even in submaximal effort.</p>
        <p>In children, <abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev> gains additional significance since the normal values of most <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> parameters are significantly influenced by age and body composition. The use of <abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev>, especially when calculated to body surface area, allows for better comparability between different age groups. This makes it a valuable tool for assessing cardiorespiratory function in both healthy and diseased children.<sup>[<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]</sup></p>
      </sec>
    </sec>
    <sec sec-type="Criteria for maximal effort in children" id="sec10">
      <title>Criteria for maximal effort in children</title>
      <p>Maximal effort during <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> is typically confirmed by a combination of physiological indicators. A classical marker is the establishment of a VO<sub>2</sub> plateau defined as the inability of VO<sub>2</sub> to increase with more than 150 ml/min or 2 ml.kg<sup>−1</sup>.min<sup>−1</sup> despite a further increase in the workload.<sup>[<xref ref-type="bibr" rid="B18">18</xref>]</sup> However, difficulty in reaching a true VO<sub>2</sub> plateau has led to the use of other criteria, including reaching an <abbrev xlink:title="respiratory exchange ratio">RER</abbrev>&gt;1.11, blood lactate &gt;8 mmol/L, <abbrev xlink:title="heart rate">HR</abbrev> &gt;90-95% of predicted HRmax, <abbrev xlink:title="ventilation">VE</abbrev>&gt;85% of predicted maximal voluntary ventilation (<abbrev xlink:title="maximal voluntary ventilation">MVV</abbrev>), rating of perceived exertion (<abbrev xlink:title="rating of perceived exertion">RPE</abbrev>) &gt;17 on a 6-20 scale, and the subjective appearance of the patient.<sup>[<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]</sup></p>
      <p>In children, determining whether maximal effort was achieved may be even more challenging due to both physiological and behavioral factors. Developmental differences in the cardiovascular, respiratory, and metabolic responses to exercise influence the typical maximal effort markers. Children often demonstrate lower lactate levels even at peak exercise<sup>[<xref ref-type="bibr" rid="B5">5</xref>]</sup> or may terminate the test before reaching high <abbrev xlink:title="respiratory exchange ratio">RER</abbrev> values. A true VO<sub>2</sub> plateau is generally rarely observed in pediatric populations, unless the children are particularly athletic.<sup>[<xref ref-type="bibr" rid="B7">7</xref>]</sup> For these reasons, interpretation of maximal effort in pediatric <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> typically relies on a combination of criteria.<sup>[<xref ref-type="bibr" rid="B21">21</xref>]</sup></p>
    </sec>
    <sec sec-type="Methodological specificities of CPET in children" id="sec11">
      <title>Methodological specificities of CPET in children</title>
      <sec sec-type="Pediatric CPET equipment" id="sec12">
        <title>Pediatric CPET equipment</title>
        <p>When conducting pediatric <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev>, careful consideration must be given to both equipment and exercise protocol selection. The child’s height is important when choosing the correct ergometer. Most manufacturers of cycle ergometers require a minimum patient height of 120 cm. Bearing in mind that according to the World Health Organization (<abbrev xlink:title="World Health Organization">WHO</abbrev>), the average height of a preschool-aged child (5 years old) is 111 cm for boys and 109 cm for girls<sup>[<xref ref-type="bibr" rid="B22">22</xref>]</sup>, this makes the use of cycle ergometry highly limited and in some cases practically impossible. Therefore, <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> is often performed on a treadmill or requires specialized pediatric ergometer equipment adapted for younger ages.<sup>[<xref ref-type="bibr" rid="B13">13</xref>]</sup> All equipment needs to be consistent with the children’s anatomical characteristics. A range of mask sizes should be available to choose from, depending on the child’s age and head circumference. Too large a mask may lead to gas leakage and hinder gas analysis, whereas using too small of a size could be uncomfortable for the child and be the reason for a premature cessation of the test.<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup></p>
      </sec>
      <sec sec-type="Protocol selection" id="sec13">
        <title>Protocol selection</title>
        <p>Protocol selection needs to consider the child’s age, height, weight, motor coordination, and level of physical training. Ramp protocols provide a more gradual workload increase, which may allow for a more precise determination of the ventilatory thresholds. However, step protocols may be preferable in cases when steady-state measurements are required or when evaluating submaximal responses.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup></p>
        <p>Protocol design may influence key parameters such as ventilatory efficiency and oxygen uptake kinetics, highlighting the need for standardization in pediatric <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> protocols. Standardized treadmill protocols may prove too difficult and lengthy for very young children. In such cases, the use of modified protocols, such as the modified Bruce treadmill protocol for children<sup>[<xref ref-type="bibr" rid="B23">23</xref>]</sup> or the Dubowy protocol<sup>[<xref ref-type="bibr" rid="B24">24</xref>]</sup> is encouraged. If using the ramp protocol, the workload intensity should be adjusted to the child’s abilities and age so that an optimal test duration of 8 – 12 minutes is achieved.<sup>[<xref ref-type="bibr" rid="B25">25</xref>]</sup> Using excessively steep ramp increments may lead to premature muscular fatigue before cardiovascular or pulmonary limitation is reached, whereas overly shallow increments may prolong the test and lead to loss of motivation. Workload increments should typically be calculated based on predicted VO<sub>2</sub>peak or estimated maximum workload, ensuring a progressive but tolerable increase of the intensity.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup></p>
      </sec>
      <sec sec-type="Motivational and compliance issues" id="sec14">
        <title>Motivational and compliance issues</title>
        <p>Maintaining attention and following the examiner’s instructions for a prolonged period of time is often challenging for very young kids. Most treadmill step protocols (Bruce) utilize 3-minute steps in order to allow for adaptation and the achievement of a steady state.<sup>[<xref ref-type="bibr" rid="B26">26</xref>]</sup> This can present a problem due to the relative monotony of the test. Moreover, the unfamiliarity of the laboratory settings, as well as the equipment (mask, electrodes, etc.), can be a source of discomfort or fear. In such cases, the role of the parent is particularly important, as they can predispose the child with encouraging words and prevent them from giving up the test too early.<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup></p>
      </sec>
    </sec>
    <sec sec-type="Safety considerations and contraindications to CPET in children" id="sec15">
      <title>Safety considerations and contraindications to CPET in children</title>
      <p><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> is generally considered a safe method for diagnostic assessment when performed by trained personnel in an appropriate laboratory setting.<sup>[<xref ref-type="bibr" rid="B25">25</xref>]</sup> Serious adverse events during <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> are rare; however, to ensure maximum safety for the patient, it is essential to perform thorough pre-test screening, especially when working with children.<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup> Prior to testing, a comprehensive medical history should be taken as well as a standard physical examination should be performed. Written informed consent from the parents or legal guardian is required prior to testing. Clear information regarding possible contraindications should be given in an understandable way.</p>
      <p>Absolute contraindications to <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> in children are largely the same as those in adults <bold>(Table <xref ref-type="table" rid="T1">1</xref>)</bold>.<sup>[<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B28">28</xref>]</sup> Additional concerns should be any condition in which near-maximal exertion might pose a significant risk to the child’s health and well-being, such as decompensated heart or respiratory failure.</p>
      <table-wrap id="T1" position="float" orientation="portrait">
        <label>Table 1.</label>
        <caption>
          <p>Absolute and relative contraindications for <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev>. Adapted from ATS/ACCP Statement on Cardiopulmonary exercise testing.<sup>[<xref ref-type="bibr" rid="B25">25</xref>]</sup></p>
        </caption>
        <table>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Absolute contraindications for <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev></bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Relative contraindications for <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev></bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Acute myocardial infarction (3–5 days)</td>
              <td rowspan="1" colspan="1">Left main coronary stenosis or its equivalent</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Unstable angina</td>
              <td rowspan="1" colspan="1">Moderate stenotic valvular heart disease</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Uncontrolled arrhythmias causing symptoms or hemodynamic compromise</td>
              <td rowspan="1" colspan="1">Severe untreated arterial hypertension at rest or hemodynamic compromise (systolic <abbrev xlink:title="Blood pressure">BP</abbrev> &gt;200 mmHg, diastolic <abbrev xlink:title="Blood pressure">BP</abbrev> &gt;120 mmHg)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Syncope</td>
              <td rowspan="1" colspan="1">Tachyarrhythmias or bradyarrhythmias</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Active endocarditis</td>
              <td rowspan="1" colspan="1">High‐degree atrioventricular block</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Acute myocarditis or pericarditis</td>
              <td rowspan="1" colspan="1">Hypertrophic cardiomyopathy</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Symptomatic severe aortic stenosis</td>
              <td rowspan="1" colspan="1">Significant pulmonary hypertension</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Uncontrolled heart failure</td>
              <td rowspan="1" colspan="1">Advanced or complicated pregnancy</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Acute pulmonary embolus or pulmonary infarction</td>
              <td rowspan="1" colspan="1">Electrolyte abnormalities</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Thrombosis of lower extremities</td>
              <td rowspan="1" colspan="1">Orthopedic impairment that compromises exercise performance</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Suspected dissecting aneurysm</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Uncontrolled asthma</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Pulmonary oedema</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Room air desaturation at rest &lt;85%</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Respiratory failure</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Acute non‐cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise (infection, renal failure, thyrotoxicosis, etc.)</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Mental impairment leading to inability to cooperate</td>
              <td rowspan="1" colspan="1"/>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Monitoring during <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> is essential to ensure patient safety. Careful evaluation of the child’s condition should include monitoring for signs of dizziness, severe dyspnea, cyanosis, chest pain, pallor, or loss of coordination.<sup>[<xref ref-type="bibr" rid="B25">25</xref>]</sup> A key component of test safety is the presence of adequately trained personnel. Pediatric <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> should be performed in the presence of clinicians capable of recognizing abnormal responses to exercise and able to provide basic and advanced pediatric life support if required. The laboratory should be equipped with appropriate pediatric resuscitation supplies, as well as a defibrillator.<sup>[<xref ref-type="bibr" rid="B25">25</xref>]</sup></p>
    </sec>
    <sec sec-type="Clinical applications of CPET in children" id="sec16">
      <title>Clinical applications of CPET in children</title>
      <p><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> provides ample opportunities for diagnosis, monitoring and prognosis in children with an array of cardiovascular or respiratory pathology. The test compliments the classical clinical examination, giving a more in-depth picture regarding the functional state of the individual.</p>
      <sec sec-type="Fitness evaluation in children" id="sec17">
        <title>Fitness evaluation in children</title>
        <p>Assessment of physical fitness in children is an important component of pediatric health evaluation, since cardiorespiratory fitness is strongly associated with health outcomes later in life.<sup>[<xref ref-type="bibr" rid="B29">29</xref>]</sup> Traditionally, physical fitness in kids can be evaluated through field tests, such as shuttle runs or timed running protocols, which provide an indirect estimate of aerobic capacity.<sup>[<xref ref-type="bibr" rid="B1">1</xref>]</sup><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> is the gold standard for aerobic fitness assessment, and it can be used to evaluate the functional capacity of healthy children and young athletes, allowing for a more detailed characterization of the physiological adaptations to exercise. Additionally, <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> can provide information regarding the predominant metabolic profile of the child and thus help guide orientation towards a sport with predominantly aerobic or anaerobic requirements.</p>
      </sec>
      <sec sec-type="CPET in obese children" id="sec18">
        <title>CPET in obese children</title>
        <p>Obesity is a condition associated with the accumulation of excessive adipose tissue and high body mass index (<abbrev xlink:title="body mass index">BMI</abbrev>). Childhood obesity proves difficult to manage and leads to numerous complications, including reduced exercise capacity. Obese children have a shorter <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> duration and reach lower values of VO<sub>2</sub>peak, as well as report higher levels of subjective symptoms of exertion.<sup>[<xref ref-type="bibr" rid="B17">17</xref>]</sup> They reach higher levels of <abbrev xlink:title="ventilation">VE</abbrev>, <abbrev xlink:title="higher respiratory rate">RR</abbrev>, and dead space ventilation (VD/VT) – an expression of the difficult adaptation to the workload increase, as well as lower ventilatory efficiency.<sup>[<xref ref-type="bibr" rid="B30">30</xref>]</sup> This in turn, leads to the faster onset of fatigue and earlier test termination.</p>
        <p><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> can be used both as a means for assessment, and for monitoring obese children during weight loss regimens and assessing their progress regarding functional parameters, as well as program compliance.<sup>[<xref ref-type="bibr" rid="B31">31</xref>]</sup> The test provides useful information for the child’s individual functional capacity so that the training regimen can be tailored towards the patients’ specific abilities.</p>
      </sec>
      <sec sec-type="CPET in children with chronic respiratory diseases" id="sec19">
        <title>CPET in children with chronic respiratory diseases</title>
        <p><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> proves useful in assessing the functional status of children with asthma, cystic fibrosis (<abbrev xlink:title="cystic fibrosis">CF</abbrev>), exercise-induced bronchoconstriction (<abbrev xlink:title="exercise-induced bronchoconstriction">EIB</abbrev>), or dyspnea of unknown origin. In the presence of functional airway obstruction, <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> can objectify the degree of airflow limitation during exercise.‌<sup>[<xref ref-type="bibr" rid="B32">32</xref>]</sup> Furthermore, it can play a role as an indirect provocation factor during bronchoprovocation testing.<sup>[<xref ref-type="bibr" rid="B33">33</xref>]</sup></p>
        <p>Multiple studies have shown kids with bronchial asthma to have a lower exercise capacity, including lower VO<sub>2</sub>peak, lower ventilatory efficiency, and lower breathing reserve (<abbrev xlink:title="breathing reserve">BR</abbrev>) compared to healthy controls. There is a positive correlation between lower VO<sub>2</sub>peak values, poor ventilatory efficiency, and higher <abbrev xlink:title="body mass index">BMI</abbrev> in kids.<sup>[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B34">34</xref>]</sup></p>
        <p><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> can be implemented as a prognostic tool in children with chronic respiratory conditions. In case of <abbrev xlink:title="cystic fibrosis">CF</abbrev>, VO<sub>2</sub>peak decline over time has been associated with a worsened functional state of the patient, which can be used as an indicator for the inclusion of more intensive pulmonary rehabilitation.<sup>[<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]</sup> Some attempts at developing prognostic models for mortality in children with <abbrev xlink:title="cystic fibrosis">CF</abbrev> based on <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> parameters have been made. The forced expiratory volume for 1 second (FEV<sub>1</sub>) and the <abbrev xlink:title="ventilation">VE</abbrev>/VCO<sub>2</sub> slope have been found to be highly predictive of mortality.<sup>[<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]</sup> In this context, <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> can be used as a tool for identifying high-risk patients. In children with pulmonary hypertension (<abbrev xlink:title="pulmonary hypertension">PH</abbrev>), VO<sub>2</sub>peak and the <abbrev xlink:title="ventilation">VE</abbrev>/VCO<sub>2</sub> slope values correlate with the severity of the condition and can be implemented as non-invasive markers for assessing the pulmonary status.<sup>[<xref ref-type="bibr" rid="B38">38</xref>]</sup></p>
      </sec>
      <sec sec-type="CPET in children with congenital heart defects and heart failure" id="sec20">
        <title>CPET in children with congenital heart defects and heart failure</title>
        <p>Studies show that in kids with congenital heart defects, aerobic capacity (measured via VO<sub>2</sub>peak) decreases four times faster compared to healthy controls.<sup>[<xref ref-type="bibr" rid="B39">39</xref>]</sup> Male gender, higher baseline VO<sub>2</sub>peak, high <abbrev xlink:title="body mass index">BMI</abbrev>, and multiple surgical interventions were found to be predictors for a greater decline. <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> has been used to assess health-related quality of life (<abbrev xlink:title="heart rate">HR</abbrev>-OoL) in children and adolescents with congenital heart defects. There is a significant correlation between VO<sub>2</sub>peak and physical well-being scores from the Kidscreen questionnaire used for assessing <abbrev xlink:title="heart rate">HR</abbrev>-OoL, confirming VO<sub>2</sub>peak as a reliable indicator of physical well-being in pediatric patients.<sup>[<xref ref-type="bibr" rid="B40">40</xref>]</sup> The <abbrev xlink:title="anaerobic threshold">AT</abbrev> also correlates with physical well-being and decreases with the increase of the severity of heart disease, suggesting a potential use as a clinical marker.</p>
      </sec>
    </sec>
    <sec sec-type="Challenges and future directions in pediatric CPET" id="sec21">
      <title>Challenges and future directions in pediatric CPET</title>
      <p>Despite the increase in the applicability of <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> in pediatric populations, several challenges remain. A major limitation is the lack of comprehensive pediatric reference values for many of the <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> parameters. Existing data is often derived from small studies with a limited number of children and thus may not always account for differences in age, sex, body composition, and levels of physical training.<sup>[<xref ref-type="bibr" rid="B41">41</xref>]</sup></p>
      <p>Furthermore, the lack of standardized pediatric protocols presents a challenge when choosing the right ergometer and exercise load for pediatric patients. Variations in protocol design, workload increments, and test duration limit the comparability of studies.<sup>[<xref ref-type="bibr" rid="B42">42</xref>]</sup> An important consideration is the sport-specific adaptations present in physically active children and young athletes, which may affect the measured parameters.<sup>[<xref ref-type="bibr" rid="B43">43</xref>]</sup> Further research should focus on large-scale population-based datasets for improving methodological standardization. Submaximal parameters such as <abbrev xlink:title="oxygen uptake efficiency slope">OUES</abbrev> and ventilatory efficiency have a potential application in pediatric practice, as they are effort-independent and as such can provide information for the functional capacity of the individual regardless of protocol usage and effort maximality.</p>
      <p>The implementation of contemporary technologies such as machine learning and artificial intelligence (<abbrev xlink:title="artificial intelligence">AI</abbrev>) may influence the way in which <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> data is interpreted.<sup>[<xref ref-type="bibr" rid="B44">44</xref>]</sup> Despite some promising developments, the clinical implementation of <abbrev xlink:title="artificial intelligence">AI</abbrev> in <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> remains limited. Current models are not sufficiently validated nor robust enough to replace the human expertise in interpreting <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> results. <abbrev xlink:title="artificial intelligence">AI</abbrev> should be considered more of a complementary tool rather than a substitute for data interpretations. Nevertheless, future advances in machine-learning models may allow <abbrev xlink:title="artificial intelligence">AI</abbrev>-assisted analysis to enhance <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> interpretation by enabling faster data processing, automated threshold identification, and improved risk stratification for both adult and pediatric populations.<sup>[<xref ref-type="bibr" rid="B45">45</xref>]</sup></p>
    </sec>
    <sec sec-type="Conclusion" id="sec22">
      <title>Conclusion</title>
      <p><abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> represents a valuable and increasingly utilized tool for assessment of the integration between cardiovascular, respiratory, and metabolic responses to exercise in children. By providing an objective measurement of the functional capacity, as well as identifying exercise-limiting factors, <abbrev xlink:title="Cardiopulmonary exercise testing">CPET</abbrev> plays an important role in evaluating children with suspected cardiopulmonary diseases, as well as in the assessment of exercise performance of young athletes. However, challenges regarding reference values and standardized protocols remain. Results interpretation may be influenced by growth-related physiological variability and sport-specific adaptations. Future studies should focus on establishing normative datasets and improving methodological standardization, as well as focus on the implementations of submaximal parameters in the pediatric population.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors have no support to report.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation>Armstrong N, Welsman JR. Aerobic fitness: what are we measuring? Med Sport Sci 2007; 50:5–25. <ext-link ext-link-type="doi" xlink:href="10.1159/000101073">doi: 10.1159/000101073</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="17387249">PMID: 17387249</ext-link>.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation>Rowland TW, American College of Sports Medicine, North American Society for Pediatric Exercise Medicine, editors. Cardiopulmonary exercise testing in children and adolescents. Champaign, IL: Human Kinetics; 2018. 1 p.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation>Alvarez-Pitti J, Herceg-Čavrak V, Wójcik M, et al. Blood pressure response to exercise in children and adolescents. Front Cardiovasc Med 2022; 9:1004508. <ext-link ext-link-type="doi" xlink:href="10.3389/fcvm.2022.1004508">doi: 10.3389/fcvm.2022.1004508</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="36247478">PMID: 36247478</ext-link>; PubMed Central PMCID: <ext-link ext-link-type="pmcid" xlink:href="PMC9561233">PMC9561233</ext-link>.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation>Armstrong N, Welsman J. Multilevel allometric modelling of maximum cardiac output, maximum arteriovenous oxygen difference, and peak oxygen uptake in 11-13-year olds. Eur J Appl Physiol 2020; 120(2):527–37. <ext-link ext-link-type="doi" xlink:href="10.1007/s00421-020-04300-0">doi: 10.1007/s00421-020-04300-0</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="31925520">PMID: 31925520</ext-link>; PubMed Central PMCID: <ext-link ext-link-type="pmcid" xlink:href="PMC6989571">PMC6989571</ext-link>.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation>Rowland TW. Children’s exercise physiology [Internet]. Champaign, IL : Human Kinetics; 2005 [cited 2026 Mar 10]. 322 p. Available from: <ext-link xlink:href="http://archive.org/details/childrensexercis0000rowl" ext-link-type="uri">http://archive.org/details/childrensexercis0000rowl</ext-link></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation>Takken T, Bongers BC, van Brussel M, et al. Cardiopulmonary exercise testing in pediatrics. Ann Am Thorac Soc 2017; 14(Suppl. 1):S123–8. <ext-link ext-link-type="doi" xlink:href="10.1513/AnnalsATS.201611-912FR">doi: 10.1513/AnnalsATS.201611-912FR</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="28398090">PMID: 28398090</ext-link>.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation>Armstrong N. Aerobic fitness and physical activity in children. Pediatr Exerc Sci 2013; 25(4):548–60. <ext-link ext-link-type="doi" xlink:href="10.1123/pes.25.4.548">doi: 10.1123/pes.25.4.548</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="24214438">PMID: 24214438</ext-link>.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation>Dotan R, Mitchell C, Cohen R, et al. Child–adult differences in muscle activation — a review. Pediatr Exerc Sci 2012; 24(1):2–21. <ext-link ext-link-type="doi" xlink:href="10.1123/pes.24.1.2">doi: 10.1123/pes.24.1.2</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="22433260">PMID: 22433260</ext-link>; PubMed Central PMCID: <ext-link ext-link-type="pmcid" xlink:href="PMC3804466">PMC3804466</ext-link>.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation>Falk B, Dotan R. Children’s thermoregulation during exercise in the heat: a revisit. Appl Physiol Nutr Metab 2008; 33(2):420–7. <ext-link ext-link-type="doi" xlink:href="10.1139/H07-185">doi: 10.1139/H07-185</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="18347699">PMID: 18347699</ext-link>.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation>Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and Interpretation: including pathophysiology and clinical applications. 5th ed. Philadelphia: Lippincott Williams &amp; Wilkins; 2012. [Internet]. [cited 2026 Mar 9]. Available from: <ext-link xlink:href="https://dokumen.pub/wasserman-whipps-principles-of-exercise-testing-andinterpretation-6.html" ext-link-type="uri">https://dokumen.pub/wasserman-whipps-principles-of-exercise-testing-andinterpretation-6.html</ext-link></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation>Paridon SM, Alpert BS, Boas SR, et al. Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth. Circulation 2006; 113(15):1905–20. <ext-link ext-link-type="doi" xlink:href="10.1161/CIRCULATIONAHA.106.174375">doi: 10.1161/CIRCULATIONAHA.106.174375</ext-link></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation>Wasserman K. The anaerobic threshold measurement in exercise testing. Clin Chest Med 1984; 5(1):77–88. PubMed <ext-link ext-link-type="pmid" xlink:href="6723245">PMID: 6723245</ext-link>.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation>Takken T, Hulzebos EH. Practical aspects of cardiopulmonary exercise testing in children. Int J Sports Med 2024; 45(06):403–10. <ext-link ext-link-type="doi" xlink:href="10.1055/a-2191-0518">doi: 10.1055/a-2191-0518</ext-link></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation>Shen Y, Zhang X, Ma W, et al. VE/VCO<sub>2</sub> slope and its prognostic value in patients with chronic heart failure. Exp Ther Med 2015; 9(4):1407–12. <ext-link ext-link-type="doi" xlink:href="10.3892/etm.2015.2267">doi: 10.3892/etm.2015.2267</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="25780443">PMID: 25780443</ext-link>; PubMed Central PMCID: <ext-link ext-link-type="pmcid" xlink:href="PMC4353809">PMC4353809</ext-link>.</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation>Baba R, Nagashima M, Goto M, et al. Oxygen uptake efficiency slope: A new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 1996; 28(6):1567–72. <ext-link ext-link-type="doi" xlink:href="10.1016/S0735-1097(96)00412-3">doi: 10.1016/S0735-1097(96)00412-3</ext-link></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation>Marinov B, Mandadzhieva S, Kostianev S. Oxygen-uptake efficiency slope in healthy 7- to 18-year-old children. Pediatr Exerc Sci2007; 19(2):159–70. <ext-link ext-link-type="doi" xlink:href="10.1123/pes.19.2.159">doi: 10.1123/pes.19.2.159</ext-link></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation>Marinov B, Kostianev S. Exercise performance and oxygen uptake efficiency slope in obese children performing standardized exercise. Acta Physiol Pharmacol Bulg 2003; 27(2-3):59–64. <ext-link ext-link-type="pmid" xlink:href="14570149">PMID: 14570149</ext-link></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation>Bassett DR, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc 2000; 32(1):70–84. <ext-link ext-link-type="doi" xlink:href="10.1097/00005768-200001000-00012">doi: 10.1097/00005768-200001000-00012</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="10647532">PMID: 10647532</ext-link>.</mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation>Garber CE, Blissmer B, Deschenes MR, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011; 43(7):1334–59. <ext-link ext-link-type="doi" xlink:href="10.1249/MSS.0b013e318213fefb">doi: 10.1249/MSS.0b013e318213fefb</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="21694556">PMID: 21694556</ext-link>.</mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation>Haile L, Gallagher Jr. M, Robertson RJ. Perceived exertion laboratory manual: From standard practice to contemporary application. New York, NY, US: Springer Science + Business Media; 2015. xxii, 322 p. <ext-link ext-link-type="doi" xlink:href="10.1007/978-1-4939-19178">doi: 10.1007/978-1-4939-19178</ext-link></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation>ACSM’s Guidelines for Exercise Testing and Prescription. ACSM [Internet]. [cited 2026 Mar 11]. Available from: <ext-link xlink:href="https://acsm.org/educationresources/books/guidelines-exercise-testing-prescription/" ext-link-type="uri">https://acsm.org/educationresources/books/guidelines-exercise-testing-prescription/</ext-link>.</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation>World Health Organization. WHO Child Growth Standards: Length/Height-for-Age. Geneva: WHO; 2006.</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation>Cumming GR, Everatt D, Hastman L. Bruce treadmill test in children: normal values in a clinic population. Am J Cardiol 1978; 41(1):69–75. <ext-link ext-link-type="doi" xlink:href="10.1016/00029149(78)90134-0">doi: 10.1016/00029149(78)90134-0</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="623008">PMID: 623008</ext-link>.</mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation>Dubowy KO, Baden W, Bernitzki S, et al. A practical and transferable new protocol for treadmill testing of children and adults. Cardiol Young 2008; 18(6):615–23. <ext-link ext-link-type="doi" xlink:href="10.1017/S1047951108003181">doi: 10.1017/S1047951108003181</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="18838025">PMID: 18838025</ext-link>.</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation>ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 2003; 167(2):211–77. <ext-link ext-link-type="doi" xlink:href="10.1164/rccm.167.2.211">doi: 10.1164/rccm.167.2.211</ext-link></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation>Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973; 85(4):546–62. <ext-link ext-link-type="doi" xlink:href="10.1016/0002-8703(73)90502-4">doi: 10.1016/0002-8703(73)90502-4</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="4632004">PMID: 4632004</ext-link>.</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation>Keyes D, Ladie DE. Cardiopulmonary Exercise Testing. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 [cited 2026 Mar 8]. Available from: <ext-link xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK557886/" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/books/NBK557886/</ext-link>. PubMed <ext-link ext-link-type="pmid" xlink:href="32491809">PMID: 32491809</ext-link>.</mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation>Albouaini K, Egred M, Alahmar A, et al. Cardiopulmonary exercise testing and its application. Postgrad Med J 2007; 83(985):675–82. <ext-link ext-link-type="doi" xlink:href="10.1136/hrt.2007.121558">doi: 10.1136/hrt.2007.121558</ext-link></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation>Ruiz JR, Castro-Piñero J, Artero EG, et al. Predictive validity of health-related fitness in youth: a systematic review. Br J Sports Med 2009; 43(12):909–23. <ext-link ext-link-type="doi" xlink:href="10.1136/bjsm.2008.056499">doi: 10.1136/bjsm.2008.056499</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="19158130">PMID: 19158130</ext-link>.</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation>McMurray RG, Ondrak KS. Effects of being overweight on ventilatory dynamics of youth at rest and during exercise. Eur J Appl Physiol 2011; 111(2):285–92. <ext-link ext-link-type="doi" xlink:href="10.1007/s00421-010-1651-z">doi: 10.1007/s00421-010-1651-z</ext-link></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation>Prado D, Silva A, Trombetta I, et al. Exercise Training associated with diet improves heart rate recovery and cardiac autonomic nervous system activity in obese children. Int J Sports Med 2010; 31(12):860–5. <ext-link ext-link-type="doi" xlink:href="10.1055/s-0030-1267158">doi: 10.1055/s-0030-1267158</ext-link></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation>Ferguson B. ACSM’s Guidelines for Exercise Testing and Prescription. 9th Ed. 2014. J Can Chiropr Assoc 2014; 58(3):328. PubMed PMID: null; PubMed Central PMCID: <ext-link ext-link-type="pmcid" xlink:href="PMC4139760">PMC4139760</ext-link>.</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation>Parsons JP, Hallstrand TS, Mastronarde JG, et al. An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2013; 187(9):1016–27. <ext-link ext-link-type="doi" xlink:href="10.1164/rccm.201303-0437ST">doi: 10.1164/rccm.201303-0437ST</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="23634861">PMID: 23634861</ext-link>.</mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation>Moreau J, Socchi F, Renoux MC, et al. Cardiopulmonary fitness in children with asthma versus healthy children. Arch Dis Child 2023; 108(3):204–10. <ext-link ext-link-type="doi" xlink:href="10.1136/archdischild-2021-323733">doi: 10.1136/archdischild-2021-323733</ext-link></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation>Weir E, Burns PD, Devenny A, et al. Cardiopulmonary exercise testing in children with cystic fibrosis: one centre’s experience. Arch Dis Child 2017; 102(5):440–4. <ext-link ext-link-type="doi" xlink:href="10.1136/archdischild-2016-310651">doi: 10.1136/archdischild-2016-310651</ext-link></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation>Bongers BC, Werkman MS, Takken T, et al. Ventilatory response to exercise in adolescents with cystic fibrosis and mild-to-moderate airway obstruction. SpringerPlus 2014; 3(1):696. <ext-link ext-link-type="doi" xlink:href="10.1186/2193-1801-3-696">doi: 10.1186/2193-1801-3-696</ext-link></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation>Hulzebos EHJ, Bomhof-Roordink H, Van De Weert-van Leeuwen PB, et al. Prediction of mortality in adolescents with cystic fibrosis. Medicine &amp; Science in Sports &amp; Exercise. 2014; 46(11):2047–52. <ext-link ext-link-type="doi" xlink:href="10.1249/MSS.0000000000000344">doi: 10.1249/MSS.0000000000000344</ext-link></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation>Rausch CM, Taylor AL, Ross H, et al. Ventilatory efficiency slope correlates with functional capacity, outcomes, and disease severity in pediatric patients with pulmonary hypertension. Int J Cardiol 2013; 169(6):445–8. <ext-link ext-link-type="doi" xlink:href="10.1016/j.ijcard.2013.10.012">doi: 10.1016/j.ijcard.2013.10.012</ext-link></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation>Gavotto A, Ladeveze M, Avesani M, et al. Aerobic fitness change with time in children with congenital heart disease: A retrospective controlled cohort study. Int J Cardiol 2023; 371:140–6. <ext-link ext-link-type="doi" xlink:href="10.1016/j.ijcard.2022.09.068">doi: 10.1016/j.ijcard.2022.09.068</ext-link></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation>Amedro P, Picot MC, Moniotte S, et al. Correlation between cardio-pulmonary exercise test variables and health-related quality of life among children with congenital heart diseases. Int J Cardiol 2016; 203:1052–60. <ext-link ext-link-type="doi" xlink:href="10.1016/j.ijcard.2015.11.028">doi: 10.1016/j.ijcard.2015.11.028</ext-link></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation>Takken T, Bongers BC, Van Brussel M, et al. Cardiopulmonary exercise testing in pediatrics. Ann Am Thorac Soc 2017; 14(Suppl. 1):S123–8. <ext-link ext-link-type="doi" xlink:href="10.1513/AnnalsATS.201611-912FR">doi: 10.1513/AnnalsATS.201611-912FR</ext-link></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation>Paridon SM, Alpert BS, Boas SR, et al. Clinical stress testing in the pediatric age group: a statement from the American Heart Association Council on Cardiovascular Disease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity in Youth. Circulation 2006; 113(15):1905–20. <ext-link ext-link-type="doi" xlink:href="10.1161/CIRCULATIONAHA.106.174375">doi: 10.1161/CIRCULATIONAHA.106.174375</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="16567564">PMID: 16567564</ext-link>.</mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation>Armstrong N, Williams J, Balding J, et al. The peak oxygen uptake of British children with reference to age, sex and sexual maturity. Europ J Appl Physiol 1991; 62(5):369–75. <ext-link ext-link-type="doi" xlink:href="10.1007/BF00634975">doi: 10.1007/BF00634975</ext-link></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation>Inbar O, Inbar O, Reuveny R, et al. A machine learning approach to the interpretation of cardiopulmonary exercise tests: development and validation. Pulm Med 2021; 2021:5516248. <ext-link ext-link-type="doi" xlink:href="10.1155/2021/5516248">doi: 10.1155/2021/5516248</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="34158976">PMID: 34158976</ext-link>; PubMed Central PMCID: <ext-link ext-link-type="pmcid" xlink:href="PMC8188599">PMC8188599</ext-link>.</mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation>Ntalianis E, Cauwenberghs N, Sabovčik F, et al. Improving cardiovascular risk stratification through multivariate time-series analysis of cardiopulmonary exercise test data. iScience 2024; 27(9):110792. <ext-link ext-link-type="doi" xlink:href="10.1016/j.isci.2024.110792">doi: 10.1016/j.isci.2024.110792</ext-link>; PubMed <ext-link ext-link-type="pmid" xlink:href="39286486">PMID: 39286486</ext-link>; PubMed Central PMCID: <ext-link ext-link-type="pmcid" xlink:href="PMC11403400">PMC11403400</ext-link>.</mixed-citation>
      </ref>
    </ref-list>
    <sec sec-type="Additional information" id="sec23">
      <title>Additional information</title>
      <sec sec-type="Ethical statements" id="sec24">
        <title>Ethical statements</title>
        <list list-type="bullet">
          <list-item>
            <p>The authors declared that no clinical trials were used in the present study.
</p>
          </list-item>
          <list-item>
            <p>The authors declared that no experiments on humans or human tissues were performed for the present study.
</p>
          </list-item>
          <list-item>
            <p>The authors declared that no informed consent was obtained from the humans, donors or donors’ representatives participating in the study.
</p>
          </list-item>
          <list-item>
            <p>The authors declared that no experiments on animals were performed for the present study.
</p>
          </list-item>
          <list-item>
            <p>The authors declared that no commercially available immortalized human and animal cell lines were used in the present study.
</p>
          </list-item>
        </list>
      </sec>
      <sec sec-type="Conflict of interest" id="sec25">
        <title>Conflict of interest</title>
        <p>The authors have declared that no competing interests exist.</p>
      </sec>
      <sec sec-type="Artificial Intelligence (AI) Use" id="sec26">
        <title>Artificial Intelligence (AI) Use</title>
        <p>The authors accept full responsibility for the content of the manuscript, including the disclosure of any use of <abbrev xlink:title="artificial intelligence">AI</abbrev>. The following <abbrev xlink:title="artificial intelligence">AI</abbrev> tools were used in the preparation of this manuscript: GPT. GPT was used for the purposes of improving language, refining writing style, assisting in literature discovery, and brainstorming.</p>
      </sec>
      <sec sec-type="Funding" id="sec27">
        <title>Funding</title>
        <p>No funding was reported.</p>
        <p>
          <bold>Author contributions</bold>
        </p>
        <p>Both authors have contributed equally to the preparation of this manuscript. They have approved the contents of this manuscript and agree with its submission to Folia Medica.</p>
      </sec>
      <sec sec-type="Author ORCIDs" id="sec28">
        <title>Author ORCIDs</title>
        <p>Blagoy Marinov <ext-link xlink:href="https://orcid.org/0000-0001-9640-1906" ext-link-type="uri">https://orcid.org/0000-0001-9640-1906</ext-link></p>
      </sec>
      <sec sec-type="Data availability" id="sec29">
        <title>Data availability</title>
        <p>All data used are referenced or included in the article.</p>
      </sec>
    </sec>
  </back>
</article>
